
Artivion (AORT) Stock Forecast & Price Target
Artivion (AORT) Analyst Ratings
Bulls say
Artivion is a global leader in the field of cardiovascular medical devices and technology, with a strong focus on aortic-centric solutions. The company's diverse portfolio of products, including aortic and mitral heart valves, allografts and patches, and surgical adhesives, has a wide reach in North America, EMEA, LATAM, and APAC. The company's recent PMA approvals and ongoing pipeline of products, including Arcevo and NEXUS, position it for long-term growth in the 10%-14% range. Despite recent challenges with the rollout of AMDS, management believes it is an air pocket and not a structural issue, and they are taking steps to overcome barriers to adoption. With a strong backlog of new accounts waiting to issue purchase orders and potential solutions to ease upfront costs, Artivion's revenue is poised to rebound. Additionally, the company is making strategic acquisitions, such as Endospan and Ascyrus Medical, to further expand its product offerings and drive future growth. Overall, Artivion's strong financials, with a 19.0% adjusted EBITDA margin and plans for debt reduction through use of FCF, make it a promising investment opportunity for the long-term.
Bears say
Artivion is facing several challenges that could have a negative impact on its financial performance and stock price. These include potential disruptions and delays in the adoption of its new products, which could adversely affect its bottom line and market share. Additionally, the company faces competition from larger and more established players in the MedTech industry, as well as regulatory and environmental risks related to its product portfolio and operations. The company's dependence on its preservation services segment also poses a risk, as it is subject to potential uncertainties in donor volume, donation quality, and fluctuations in demand.
This aggregate rating is based on analysts' research of Artivion and is not a guaranteed prediction by Public.com or investment advice.
Artivion (AORT) Analyst Forecast & Price Prediction
Start investing in Artivion (AORT)
Order type
Buy in
Order amount
Est. shares
0 shares